Stifel Q1 2026 Earnings Modest EPS Beat Amid Market Challenges Shares Edge Lower Supernus Pharmaceuticals SUPN Q1 2026 Earnings Robust EPS Beat Overshadowed by Mild Share Decline AFRM Q1 2026 Earnings EPS Beat Drives DoubleDigit Stock Rally HCKT Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally CLDI Q4 2025 Earnings Smallerthanexpected loss highlights progress in clinicalstage biotherapeutics COCH Q1 2026 Earnings EPS Beats Estimates Despite PreRevenue Status Stock Declines